Net Loss Per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Net Loss Per Share [Abstract]

Schedule of Net Loss Per Share

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Net loss	$	(5,427,709	)	$	(3,127,269	)	$	(14,357,325	)	$	(8,508,592	)
Net loss: Non-controlling interest		(242,244	)		(126,865	)		(549,190	)		(330,675	)
Net loss attributable to Heat Biologics, Inc.	$	(5,185,465	)	$	(3,000,404	)	$	(13,808,135	)	$	(8,177,917	)
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.—basic and diluted		8,408,376			6,469,272			7,880,637			6,445,129
Net loss per share attributable to Heat Biologics, Inc.—basic and diluted	$	(0.62	)	$	(0.46	)	$	(1.75	)	$	(1.27	)

	For the years ended December 31,
	2014			2013
Net loss	$	(12,243,211	)	$	(6,609,864	)
Net loss: Non-controlling interest		(454,394	)		(198,516	)
Beneficial conversion charge		—			(2,300,000	)
Preferred Stock Dividend		—			(361,668	)
Net loss applicable to common stockholders	$	(11,788,817	)	$	(9,073,016	)
Weighted-average number of common shares used in net loss per share applicable to common stockholders—basic and diluted		6,454,866			3,747,357
Net loss per share applicable to common stockholders—basic and diluted	$	(1.83	)	$	(2.42	)

Schedule of Potentially Dilutive Securities

	For the Nine Months Ended September 30,
	2015		2014
Outstanding stock options		1,106,895		836,961
Common stock warrants		17,392		17,392
Underwriters warrants		125,000		125,000

	For the years ended December 31,
	2014		2013
Outstanding stock options		1,018,590		633,482
Common stock warrants		142,392		178,159